Evidence-based management of rapidly progressing systemic sclerosis

作者: Dinesh Khanna , Christopher P. Denton

DOI: 10.1016/J.BERH.2009.12.002

关键词:

摘要: Systemic sclerosis has the highest case-specific mortality of any auto-immune rheumatic diseases, as well causing major morbidity. It is a clinical challenge and one that previously provoked substantial nihilism due to limited therapeutic options available perceived lack evidence for effectiveness those treatments are currently in use. However, this situation changing; there emerging data supporting efficacy some treatment approaches patient group together with growing number exciting potential novel moving into arena. Some recent trials reviewed discussed detail.

参考文章(59)
Sogol Amjadi, Paul Maranian, Daniel E. Furst, Philip J. Clements, Weng Kee Wong, Arnold E. Postlethwaite, Puja P. Khanna, Dinesh Khanna, , Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis & Rheumatism. ,vol. 60, pp. 2490- 2498 ,(2009) , 10.1002/ART.24681
Paul J. DeMarco, Michael H. Weisman, James R. Seibold, Daniel E. Furst, Weng Kee Wong, Eric L. Hurwitz, Maureen Mayes, Barbara White, Fredrick Wigley, Walter Barr, Larry Moreland, Thomas A. Medsger, Virginia Steen, Richard W. Martin, David Collier, Arthur Weinstein, Edward Lally, John Varga, Steven R. Weiner, Brian Andrews, Micha Abeles, Philip J. Clements, Predictors and outcomes of scleroderma renal crisis: The high‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis trial Arthritis & Rheumatism. ,vol. 46, pp. 2983- 2989 ,(2002) , 10.1002/ART.10589
C.S. Samuel, T.D. Hewitson, Relaxin in cardiovascular and renal disease. Kidney International. ,vol. 69, pp. 1498- 1502 ,(2006) , 10.1038/SJ.KI.5000264
Robert W. Sjogren, Gastrointestinal features of scleroderma. Current Opinion in Rheumatology. ,vol. 8, pp. 569- 575 ,(1996) , 10.1097/00002281-199611000-00012
H. Penn, A.J. Howie, E.J. Kingdon, C.C. Bunn, R.J. Stratton, C.M. Black, A. Burns, C.P. Denton, Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM: An International Journal of Medicine. ,vol. 100, pp. 485- 494 ,(2007) , 10.1093/QJMED/HCM052
Alfiya Akhmetshina, Clara Dees, Margarita Pileckyte, Britta Maurer, Roland Axmann, Astrid Jüngel, Jochen Zwerina, Steffen Gay, Georg Schett, Oliver Distler, Jörg HW Distler, None, Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis The FASEB Journal. ,vol. 22, pp. 2214- 2222 ,(2008) , 10.1096/FJ.07-105627
Anthony J. Gerbino, Christopher H. Goss, Jerry A. Molitor, Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease. Chest. ,vol. 133, pp. 455- 460 ,(2008) , 10.1378/CHEST.06-2861
L Teixeira, L Mouthon, A Mahr, A Berezne, C Agard, M Mehrenberger, L-H Noel, P Trolliet, C Frances, J Cabane, L Guillevin, , Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Annals of the Rheumatic Diseases. ,vol. 67, pp. 110- 116 ,(2008) , 10.1136/ARD.2006.066985
Arnold E. Postlethwaite, Weng Kee Wong, Philip Clements, Soumya Chatterjee, Barri J. Fessler, Andrew H. Kang, Joseph Korn, Maureen Mayes, Peter A. Merkel, Jerry A. Molitor, Larry Moreland, Naomi Rothfield, Robert W. Simms, Edwin A. Smith, Robert Spiera, Virginia Steen, Kenneth Warrington, Barbara White, Frederick Wigley, Daniel E. Furst, A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease. Arthritis & Rheumatism. ,vol. 58, pp. 1810- 1822 ,(2008) , 10.1002/ART.23501
Charlie Strange, Marcy B. Bolster, Michael D. Roth, Richard M. Silver, Arthur Theodore, Jonathan Goldin, Philip Clements, Joanie Chung, Robert M. Elashoff, Robert Suh, Edwin A. Smith, Daniel E. Furst, Donald P. Tashkin, , Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 177, pp. 91- 98 ,(2008) , 10.1164/RCCM.200705-655OC